Dosimetric characterization of a nanophotonic scintillator and applications to real-time in-vivo total body irradiation dosimetry

Technical Summary: Dosimetric Characterization of a Nanophotonic Scintillator and Applications to Real-Time In-Vivo Total Body Irradiation Dosimetry

Problem Statement
Scintillating materials are integral to radiotherapy dosimetry, quality assurance (QA), and medical imaging, yet their clinical utility is often constrained by limited light yield. This limitation necessitates the use of expensive, bulky light-amplification hardware, such as photomultiplier tubes and specialized cameras, which increases system costs and spatial requirements. While nanophotonic structures have been proposed to enhance light output in bulk scintillators, the dosimetric behavior of such coatings—specifically regarding dose-rate dependence, linearity, and energy dependence—had not been established. Furthermore, real-time in-vivo dosimetry for Total Body Irradiation (TBI) remains challenging due to low dose rates and weak light signals, which typically require costly intensified camera systems for detection.

Methodology
The authors performed the first dosimetric characterization of a cerium-doped yttrium aluminum garnet (YAG:Ce) scintillator coated with a nanophotonic surface structure. The experimental setup utilized a single 4.5 cm × 1.5 cm YAG:Ce scintillator, half of which was patterned with a subwavelength photonic crystal coating (fabricated via nanoimprint lithography and thermal annealing of chalcogenide glass) and half left unpatterned. This configuration allowed for a direct, side-by-side comparison of conventional versus nanophotonic surfaces under identical irradiation conditions.

Dosimetric characterization was conducted using a clinical linear accelerator (Varian) with a 3D-printed light-tight enclosure housing an off-axis monochrome CMOS camera. Absolute dose measurements were obtained using dose-calibrated radiochromic film (Gafchromic EBT-XD) co-registered to the scintillator images. The study evaluated:

• Light Output and CNR: Signal intensity and contrast-to-noise ratio (CNR) across varying camera exposure times.
• Dose-Rate Dependence: Signal response at dose rates ranging from 400 to 2,000 MU/minute.
• Linearity and Energy Dependence: Signal response across multiple photon (6, 10, 15 MV) and electron (6–20 MeV) energies.
• Clinical Application (TBI): The scintillator was tested in a mock TBI setup using an anthropomorphic phantom at head, chest, and diaphragm positions. Signals were captured using both a scientific CMOS camera (with room lights dimmed) and a consumer-grade smartphone camera (with room lights off).

Key Results

• Light Enhancement: The nanophotonic scintillator demonstrated a 4.1-fold increase in light yield compared to the conventional scintillator for the same delivered dose.
• Image Quality: There was a 3.7-fold increase in the contrast-to-noise ratio (CNR) for the nanophotonic version. This enhancement plateaued at a 200 ms camera exposure, enabling high temporal resolution without sacrificing signal quality.
• Dosimetric Properties:
  • Dose-Rate Independence: The nanophotonic scintillator exhibited no significant dependence on dose rate, with signal deviations remaining within ±0.5% across the tested range (400–2,000 MU/minute).
  • Linearity: The device showed a linear dose response ($R^2 = 1.00$) for all tested photon and electron energies.
  • Energy Dependence: A modest energy dependence was observed, consistent with the intrinsic properties of the YAG:Ce material rather than the coating. Separate calibration curves are recommended for different energies, though all data points fell within 2.5% (photons) and 4% (electrons) of a common fit.
• TBI Feasibility: In the TBI phantom study, the nanophotonic scintillator produced a clearly detectable signal at all tested positions using both the CMOS camera (with room lights on) and the smartphone camera (with lights off). In contrast, the signal from the conventional scintillator was undetectable against background noise in both configurations.

Significance and Claims
The authors claim that this work represents the first dosimetric characterization of a nanophotonic scintillator, demonstrating that the nanophotonic structure significantly enhances light output without negatively impacting fundamental dosimetric properties such as linearity, dose-rate independence, or energy response.

The study posits that this technology could enable real-time in-vivo TBI dosimetry using cost-effective, accessible camera systems (such as consumer smartphones) rather than expensive intensified cameras. By overcoming the light yield limitations of conventional scintillators, this approach addresses the need for immediate dose verification in complex TBI treatments, potentially replacing passive detectors (TLDs, OSLDs) that suffer from readout delays or active detectors (diodes, MOSFETs) that require frequent recalibration due to energy and angular dependencies.

The authors conclude that while further refinement is needed, nanophotonic scintillators hold promise for improving both dosimetry equipment and X-ray imaging detectors, potentially allowing for reduced patient doses or superior image quality in diagnostic imaging. They note that future work should investigate radiation damage, temperature/angular dependencies, and the application of similar strategies to tissue-equivalent plastic scintillators for small-field dosimetry.